Jennifer Drake - AYR Strategies Chief Officer
| AYRWF Stock | USD 0.72 0.05 6.49% |
Insider
Jennifer Drake is Chief Officer of AYR Strategies Class
| Phone | 646 977 7914 |
| Web | https://www.ayrwellness.com |
AYR Strategies Management Efficiency
The company has return on total asset (ROA) of (0.022) % which means that it has lost $0.022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0642) %, meaning that it generated substantial loss on money invested by shareholders. AYR Strategies' management efficiency ratios could be used to measure how well AYR Strategies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Daniel Shaker | Green Thumb Industries | 52 | |
| Linda Marsicano | Green Thumb Industries | 55 | |
| Darren Esq | Verano Holdings Corp | 39 | |
| Jon Levine | Marimed | 58 | |
| Destiny Thompson | Verano Holdings Corp | 42 | |
| Christian Ocasio | Goodness Growth Holdings | 41 | |
| Sara Gullickson | Marimed | 38 | |
| Jason Pernell | Trulieve Cannabis Corp | 45 | |
| Steve West | Marimed | N/A | |
| Harris Rabin | Goodness Growth Holdings | 48 | |
| Jake Graves | Cresco Labs | N/A | |
| Timothy Shaw | Marimed | 45 | |
| Charles Finnie | Marimed | N/A | |
| Samuel Dorf | Verano Holdings Corp | N/A | |
| Brett Summerer | Verano Holdings Corp | 46 | |
| Michael Schroeder | Goodness Growth Holdings | 56 | |
| Christine Hersey | Trulieve Cannabis Corp | N/A | |
| Dennis Olis | Cresco Labs | 60 | |
| Jonathan Ross | Vext Science | N/A | |
| Stephen MD | Goodness Growth Holdings | 48 | |
| Stephan Bankosz | Vext Science | N/A | |
Management Performance
| Return On Equity | -0.0642 | |||
| Return On Asset | -0.022 |
AYR Strategies Class Leadership Team
Elected by the shareholders, the AYR Strategies' board of directors comprises two types of representatives: AYR Strategies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AYR. The board's role is to monitor AYR Strategies' management team and ensure that shareholders' interests are well served. AYR Strategies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AYR Strategies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan JD, Chairman, Founder | ||
| Sarvesh Mathur, Chief Officer | ||
| Robert Vanisko, Head Communications | ||
| Jeff Finnerty, Chief Officer | ||
| Paul Fisher, Chief Officer | ||
| Jennifer Drake, Chief Officer | ||
| Brad Asher, Chief Officer | ||
| James Mendola, Head MA | ||
| Anya Varga, Chief Officer | ||
| David Goubert, President |
AYR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is AYR Strategies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0642 | |||
| Return On Asset | -0.022 | |||
| Profit Margin | (0.13) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 656.77 M | |||
| Shares Outstanding | 59.02 M | |||
| Shares Owned By Insiders | 1.84 % | |||
| Shares Owned By Institutions | 7.34 % | |||
| Price To Book | 0.13 X | |||
| Price To Sales | 0.25 X |
Currently Active Assets on Macroaxis
Other Information on Investing in AYR OTC Stock
AYR Strategies financial ratios help investors to determine whether AYR OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AYR with respect to the benefits of owning AYR Strategies security.